UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways-Reference-Cited by-同舟云学术

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways

Published:2023-01 Issue: Volume:553 Page:215994
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lacombe Louis,Hovington Hélène,Brisson Hervé,Mehdi Sadia,Beillevaire Déborah,Émond Jean-Philippe,Wagner Antoine,Villeneuve Lyne,Simonyan David,Ouellet Véronique,Barrès Véronique,Latour Mathieu,Aprikian Armen,Bergeron Alain,Castonguay Vincent,Couture Félix,Chevalier Simone,Brimo Fadi,Fazli Ladan,Fleshner Neil,Gleave Martin,Karakiewicz Pierre I.,Lattouf Jean-Baptiste,Trudel Dominique,van der Kwast Theodorus,Mes-Masson Anne-Marie,Pouliot Frédéric,Fradet Yves,Audet-Walsh Etienne,Saad Fred,Guillemette Chantal,Lévesque Eric

Funder

CHU de Quebec-Universite Laval

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Cancer Treatment and Survivorship Statistics;Miller,2019

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N. Engl. J. Med.,2011

3. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N. Engl. J. Med.,2013

4. Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: outcomes from the randomized controlled phase 3 AFFIRM trial;Loriot;Cancer,2017

5. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N. Engl. J. Med.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway;Cancer Letters;2024-10

2. Identifying Comprehensive Genomic Alterations and Potential Neoantigens for Cervical Cancer Immunotherapy in a Cohort of Chinese Squamous Cell Carcinoma of the Cervix;BIOMED ENVIRON SCI;2024

3. The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression;Journal of Clinical Investigation;2024-04-16

4. The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis;Neoplasma;2024

5. Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing;International Journal of Molecular Sciences;2023-11-27